- Home
- CNET vs APM Comparison
CNET vs APM Comparison
Compare CNET & APM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CNET
- APM
- Stock Information
- Founded
- CNET 2003
- APM 2010
- Country
- CNET China
- APM United Kingdom
- Employees
- CNET N/A
- APM N/A
- Industry
- CNET Advertising
- APM Biotechnology: Pharmaceutical Preparations
- Sector
- CNET Consumer Discretionary
- APM Health Care
- Exchange
- CNET Nasdaq
- APM Nasdaq
- Market Cap
- CNET 4.2M
- APM 4.0M
- IPO Year
- CNET N/A
- APM 2018
- Fundamental
- Price
- CNET $1.74
- APM $0.74
- Analyst Decision
- CNET
- APM
- Analyst Count
- CNET 0
- APM 0
- Target Price
- CNET N/A
- APM N/A
- AVG Volume (30 Days)
- CNET 18.0K
- APM 69.7K
- Earning Date
- CNET 11-19-2024
- APM 12-27-2024
- Dividend Yield
- CNET N/A
- APM N/A
- EPS Growth
- CNET N/A
- APM N/A
- EPS
- CNET N/A
- APM N/A
- Revenue
- CNET $18,458,000.00
- APM $431,378.00
- Revenue This Year
- CNET N/A
- APM $157,729.10
- Revenue Next Year
- CNET N/A
- APM N/A
- P/E Ratio
- CNET N/A
- APM N/A
- Revenue Growth
- CNET N/A
- APM N/A
- 52 Week Low
- CNET $1.47
- APM $0.46
- 52 Week High
- CNET $4.96
- APM $17.49
- Technical
- Relative Strength Index (RSI)
- CNET 44.10
- APM 41.12
- Support Level
- CNET $1.62
- APM $0.73
- Resistance Level
- CNET $1.85
- APM $0.78
- Average True Range (ATR)
- CNET 0.11
- APM 0.09
- MACD
- CNET 0.01
- APM 0.04
- Stochastic Oscillator
- CNET 25.00
- APM 64.47
About CNET ZW Data Action Technologies Inc.
ZW Data Action Technologies Inc is engaged in providing Internet advertising, precision marketing, e-commerce online to offline (O2O) advertising and marketing services as well as the related data and technical services to small and medium enterprises in the PRC. It offers a variety channels of advertising and marketing services through its system, including distribution of the right to use search engine marketing services, provision of online advertising placements on its web portals, provision of ecommerce O2O advertising and marketing services and provision of other related value-added data and technical services to maximize market exposure and effectiveness for clients.
About APM Aptorum Group Limited
Aptorum Group Ltd clinical-stage biopharmaceutical company. It is engaged in the discovery, development, and commercialization of therapeutic assets to treat diseases with unmet medical needs, particularly in oncology (including orphan oncology indications) and infectious diseases. The company operates in two segments: Therapeutics and Non-Therapeutics. The projects are ALS-4, SACT-1, and RPIDD. It is also engaged in providing healthcare services.